Tetradrip Pharma Private Limited

Pharmaceutical company specializing in tetra dextrose and other medical products for hospitals.

2013 | Burdwan, West Bengal (India) | Active
Last Updated:

Tetradrip Pharma Profile

Key Indicators

  • Authorised Capital ₹ 12.00 Cr
  • Paid Up Capital ₹ 6.19 Cr
  • Company Age 11 Year, 10 Months
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 4.23 Cr
  • Revenue Growth 507.63%
  • Profit Growth 104.45%
  • Ebitda -52.39%
  • Net Worth 18.49%
  • Total Assets 6.85%

About Tetradrip Pharma

Tetradrip Pharma Private Limited (TPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 17 April 2013 and has a history of 11 years and ten months. Its registered office is in Burdwan, West Bengal, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 12.00 Cr and a paid-up capital of Rs 6.19 Cr.

The company currently has active open charges totaling ₹4.23 Cr.

Manoj Gupta and Swati Gupta serve as directors at the Company.

Company Details

  • Location

    Burdwan, West Bengal, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    pharmaimpexlab.com

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U33111WB2013PTC192301

  • Company No.

    192301

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    17 Apr 2013

  • Date of AGM

    31 Dec 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Kolkata

Industry

Pharma

Who are the key members and board of directors at Tetradrip Pharma?

Board Members (2)

NameDesignationAppointment DateStatus
Manoj Gupta Country flag representing In Director 06-Dec-2019Current
Swati Gupta Country flag representing In Director 06-Dec-2019Current

Financial Performance of Tetradrip Pharma.

Tetradrip Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 507.63% increase. The company also saw a substantial improvement in profitability, with a 104.45% increase in profit. The company's net worth Soared by an impressive increase of 18.49%.

Tetradrip Pharma revenue growth over time
Tetradrip Pharma profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
507.63%
Revenue from Operations
370.69%
Total Assets
6.85%
Profit or Loss
104.45%
Net Worth
18.49%
EBITDA
-52.39%

What is the Ownership and Shareholding Structure of Tetradrip Pharma?

In 2023, Tetradrip Pharma had a promoter holding of 88.00% and a public holding of 12.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹4.23 Cr

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Others : 4.23 Cr

Latest Charge Details

DateLenderAmountStatus
27 Aug 2015Others₹4.23 CrOpen

How Many Employees Work at Tetradrip Pharma?

Tetradrip Pharma has a workforce of 69 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Tetradrip Pharma Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Tetradrip Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tetradrip Pharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Tetradrip Pharma

Recent activity within the organization

  • Annual General Meeting

    Tetradrip Pharma Private Limited last Annual general meeting of members was held on 31 Dec 2023 as per latest MCA records.

  • Balance Sheet

    Tetradrip Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Kolkata.

  • Charges

    A charge with Others of Rs. 4.23 Cr registered on 27 Aug 2015 with Charge ID 10611540 was modified on 20 Feb 2023.

  • Director Appointment

    Manoj Gupta was appointed as a Director was appointed as a Director on 06 Dec 2019 & has been associated with this company since 5 years 2 months .

  • Director Appointment

    Swati Gupta was appointed as a Director was appointed as a Director on 06 Dec 2019 & has been associated with this company since 5 years 2 months .

  • Charges

    A charge with Others amounted to Rs. 4.23 Cr with Charge ID 10611540 was registered on 27 Aug 2015.

Frequently asked questions

  • What is the Incorporation or founding date of Tetradrip Pharma Private Limited?

    Tetradrip Pharma Private Limited was incorporated on 17 Apr 2013.

  • What is authorized share capital and paid-up capital of Tetradrip Pharma Private Limited?

    The authorized share capital of Tetradrip Pharma Private Limited is ₹ 12.00 Cr and paid-up capital is ₹ 6.19 Cr.

  • Who are the current board members & directors of Tetradrip Pharma Private Limited?

    Currently 2 directors are associated with Tetradrip Pharma Private Limited.

    • Manoj Gupta
    • Swati Gupta

  • What is the registered address of Tetradrip Pharma Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Tetradrip Pharma Private Limited is Vill P.O.- Barakashiara Dist.- Burdwan, West Bengal, India, 713141.

  • What is the corporate identification number (CIN) and company number of Tetradrip Pharma Private Limited?

    The corporate identification number (CIN) of Tetradrip Pharma Private Limited is U33111WB2013PTC192301 and the company number is 192301 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Tetradrip Pharma Private Limited?

    The Official website of Tetradrip Pharma Private Limited is https://www.pharmaimpexlab.com

  • What has been the recent revenue trend for Tetradrip Pharma Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Tetradrip Pharma Private Limited has risen by 507.63%.

  • How many employees does Tetradrip Pharma Private Limited currently have?

    As Per 2023 financial reports, 69 employees are currently employed by Tetradrip Pharma Private Limited.

  • What change has been observed in the net worth of Tetradrip Pharma Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Tetradrip Pharma Private Limited has experienced an upsurge of 18.49%.

  • What are the total open charges for Tetradrip Pharma Private Limited?

    As per the financial statements for fiscal Year 2023, The total open charges for Tetradrip Pharma Private Limited amount to ₹ 4.23 Cr.

  • When was the last Balance Sheet of Tetradrip Pharma Private Limited filed with the ROC?

    The most recent Balance Sheet for Tetradrip Pharma Private Limited was filed with the ROC on 31 Mar 2023.

People also Viewed

Similar Companies Based on Drug Formulation & Development